SQSTM1 Knockout HeLa Cell Line
Cat.No.:
EDC07625
Species:
Human
Cell Name:
HeLa
Gene:
SQSTM1
Gene ID:
8878
Size:
1×10⁶cells
SQSTM1 Knockout Cell Line (Hela) is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performance Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC07625 |
|---|---|
| Product Name | SQSTM1 Knockout Hela Cell Line |
| Cell Line | Hela |
| Cellosaurus ID | CVCL_0030 |
| Cell Line Synonyms | HELA, Hela, He La, He-La, HeLa-CCL2, Henrietta Lacks cells, Helacyton gartleri |
| Gene | SQSTM1 |
| NCBI Gene ID | |
| Gene Synonyms | A170|DMRV|EBIAP|FTDALS3|NADGP|OSIL|PDB3|ZIP3|p60|p62|p62B |
| Summary |
This gene encodes a multifunctional protein that binds ubiquitin and regulates activation of the nuclear factor kappa-B (NF-kB) signaling pathway. The protein functions as a scaffolding/adaptor protein in concert with TNF receptor-associated factor 6 to mediate activation of NF-kB in response to upstream signals. Alternatively spliced transcript variants encoding either the same or different isoforms have been identified for this gene. Mutations in this gene result in sporadic and familial Paget disease of bone. [provided by RefSeq, Mar 2009]
|
| Associated Diseases | Cervical Carcinoma |
| Morphology | Adherent |
| Passage Ratio | 1/5, 2days |
| Complete Culture Medium | MEM + 10% FBS |
| Freezing Medium | 70%Complete culture medium+ 20% FBS+ 10% DMSO |
| QC | Indels validated by Sanger sequencing; sterility confirmed via microbial testing. |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: HeLa | STR Info (Cell bank) Cell Line: HeLa | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | X | ||
| CSF1PO | 9 | 10 | 9 | 10 |
| D1S1656 | 12 | 15 | 12 | 15 |
| D2S1338 | 17 | 17 | ||
| D3S1358 | 15 | 18 | 15 | 18 |
| D5S818 | 11 | 12 | 11 | 12 |
| D6S1043 | 18 | 18 | ||
| D7S820 | 8 | 12 | 8 | 12 |
| D8S1179 | 12 | 13 | 12 | 13 |
| D12S391 | 20 | 25 | 20 | 25 |
| D13S317 | 12 | 14 | 12 | 14 |
| D16S539 | 9 | 10 | 9 | 10 |
| D18S51 | 16 | 16 | ||
| D19S433 | 13 | 14 | 13 | 14 |
| D21S11 | 27 | 28 | 27 | 28 |
| FGA | 18 | 21 | 18 | 21 |
| Penta D | 8 | 15 | 8 | 15 |
| Penta E | 7 | 17 | 7 | 17 |
| TPOX | 8 | 12 | 8 | 12 |
| VWA | 16 | 18 | 16 | 18 |
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying SQSTM1 function, SQSTM1 Knockout HeLa Cell Line or SQSTM1 overexpression HeLa Cell Line?
The choice depends on whether you are studying p62's role as a selective autophagy receptor or its functions in NF-κB and Nrf2/Keap1 signaling. The Knockout line is the standard tool for asking whether p62 is required for selective autophagy of ubiquitinated cargo (aggrephagy, mitophagy, xenophagy). Overexpression is useful for studying p62's role in inclusion body formation or for testing p62 condensation/LLPS behavior.
For autophagy research, the EDITGENE p62 Knockout in HeLa is a workhorse tool — HeLa has been the principal cell line for selective autophagy mechanism studies, with extensive published p62-dependent phenotypes. This product complements the parallel p62 Knockout in HEK293; HeLa is preferred for imaging-based aggrephagy studies given its flat morphology and well-characterized autophagy machinery. Rescue with wild-type, UBA-mutant (ubiquitin-binding-deficient), or LIR-mutant (LC3-binding-deficient) p62 enables comprehensive selective autophagy dissection.
What are the application scenarios for this model?
Primary applications:
• Selective autophagy assays: aggrephagy (puromycin-induced aggregates), mitophagy (CCCP-induced), and xenophagy assays in the absence of p62.
• Imaging-based autophagy: LC3 puncta, p62 puncta dynamics, and autophagic flux measurement using imaging — HeLa's flat morphology supports high-resolution imaging.
• Inclusion body formation: protein aggregate accumulation assays following proteasome inhibition.
• Cargo recognition studies: rescue with UBA-mutant or LIR-mutant p62 to dissect ubiquitin-binding versus LC3-engagement functions.
EDITGENE recommends this model for researchers investigating selective autophagy, particularly imaging-based studies of p62-dependent cargo sorting.
Is this SQSTM1 Knockout HeLa Cell Line compatible with overexpression rescue experiments?
Yes. p62 rescue experiments in HeLa are well-established for autophagy research:
• Construct design: use a codon-modified SQSTM1 sequence with a small N- or C-terminal tag (FLAG, HA, GFP for imaging). p62 contains multiple functional domains (PB1, ZZ, TB, LIR, KIR, UBA) — small tags should be used to minimize domain disruption.
• Domain-specific rescue panel: UBA mutation (K7A or domain deletion) abolishes ubiquitin binding; LIR mutation (W340A) abolishes LC3 binding — these constitute the standard selective autophagy specificity controls.
• PB1-mutant rescue: PB1 domain mutations (D69A) abolish p62 oligomerization, separating LLPS-dependent functions from non-condensate functions.
• Functional readout: rescue should restore selective autophagy of aggregated substrates and p62 puncta dynamics imaged in HeLa's flat morphology background.
HeLa transduces efficiently with lentivirus; its imaging compatibility makes it particularly well-suited for fluorescent p62 rescue construct studies.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
Related Publications
Removal of hypersignaling endosomes by simaphagy.
IF=14.3
Autophagy
TBC1D4 antagonizes RAB2A-mediated autophagic and endocytic pathways.
IF=14.3
Autophagy
ZDHHC7-mediated -palmitoylation of ATG16L1 facilitates LC3 lipidation and autophagosome formation.
IF=14.3
Autophagy
SARS-CoV-2 NSP13 Inhibits Type I IFN Production by Degradation of TBK1 via p62-Dependent Selective Autophagy.
IF=3.4
Journal of immunology (Baltimore, Md. : 1950)
This KO model may be useful for:
- Investigating selective autophagy mechanisms, including lipidation, autophagosome formation, and receptor-mediated degradation.
- Studying endosomal signaling regulation and removal via autophagy-dependent pathways.
- Exploring the role of p62 in host-pathogen interactions, particularly viral immune evasion.
- Functional validation of p62-dependent cargo recognition in autophagic and endocytic crosstalk.
- Screening for modulators of p62-mediated selective autophagy in disease contexts.
download